Core Viewpoint - Encompass Health (EHC) has been upgraded to a Zacks Rank 1 (Strong Buy), indicating a positive outlook on its earnings estimates, which significantly influence stock prices [1][3]. Earnings Estimates and Stock Price Impact - The Zacks rating system is based on changes in earnings estimates, which are strongly correlated with stock price movements, particularly due to institutional investors adjusting their valuations based on these estimates [4][6]. - For the fiscal year ending December 2025, Encompass Health is expected to earn $4.98 per share, reflecting a 12.4% increase from the previous year, with a 5.5% rise in the Zacks Consensus Estimate over the past three months [8]. Zacks Rating System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [7]. - Only the top 5% of Zacks-covered stocks receive a 'Strong Buy' rating, indicating superior earnings estimate revisions, which positions Encompass Health favorably for potential market-beating returns [9][10].

Company Overview - Encompass Health (EHC) currently holds a Momentum Style Score of A, indicating strong momentum characteristics [2] - The company has a Zacks Rank of 2 (Buy), suggesting a favorable outlook for investors [3] Price Performance - EHC shares have increased by 2.88% over the past week, outperforming the Zacks Medical - Outpatient and Home Healthcare industry, which rose by 2.41% [5] - Over the past month, EHC's price change is 19.07%, significantly higher than the industry's 2.41% [5] - In the last quarter, EHC shares have risen by 16.8%, and over the past year, they have gained 40.17%, while the S&P 500 has moved -5.55% and 13.72%, respectively [6] Trading Volume - EHC's average 20-day trading volume is 1,151,747 shares, which serves as a bullish indicator when combined with rising stock prices [7] Earnings Outlook - In the past two months, 7 earnings estimates for EHC have been revised upwards, with no downward revisions, leading to an increase in the consensus estimate from $4.80 to $4.96 [9] - For the next fiscal year, 7 estimates have also moved upwards without any downward revisions [9] Conclusion - Given the strong price performance, positive earnings outlook, and high momentum score, EHC is positioned as a solid investment opportunity [11]

The Company will award research-funding grants totaling up to $60,000BIRMINGHAM, Ala., May 2, 2025 /PRNewswire/ -- Encompass Health is pleased to announce the opening of its request for 2025 research grant applications due Sept. 30, 2025, at 5 p.m. EST. The grants, totaling up to $60,000, will be awarded for the investigation of the impact or effectiveness of therapies in the inpatient rehabilitation facility post-acute care setting, knowledge translation or implementation science. Grant recipients do not h ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ______________________________ FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-10315 ______________________________ Encompass Health Corporation (Exact name of Registrant as specified in its Charter) (State or Other Jurisdi ...

Financial Data and Key Metrics Changes - The preliminary voting results indicate that stockholders overwhelmingly approved all proposals, including the election of 10 directors and the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm [12]. Business Line Data and Key Metrics Changes - No specific business line data or key metrics were discussed during the meeting [11][14]. Market Data and Key Metrics Changes - There were no specific market data or key metrics changes mentioned in the meeting [11][14]. Company Strategy and Development Direction and Industry Competition - The meeting focused on the election of directors and the approval of compensation plans, indicating a stable governance structure and commitment to performance incentives [9][10]. Management's Comments on Operating Environment and Future Outlook - Management expressed gratitude towards employees for their dedication and hard work, emphasizing the company's commitment to being a leading healthcare provider [15][16]. Other Important Information - The meeting had no questions submitted from stockholders, indicating a lack of immediate concerns or inquiries regarding the company's operations or future plans [11][14]. Q&A Session All Questions and Answers Question: Were there any questions regarding the proposals? - No questions regarding the proposals were submitted through the annual meeting website [11]. Question: Were there any general questions about the business of the company? - No general questions were submitted through the annual meeting website [14].

BIRMINGHAM, Ala., April 28, 2025 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will participate in the BofA Securities 2025 Healthcare Conference, which is being held May 13-15, 2025.Encompass Health's Executive Vice President and Chief Financial Officer Doug Coltharp will participate in a fireside chat on Tuesday, May 13, 2025, from 8:40-9:10 a.m. PT.The presentation will be webcast live and available at investor.encompasshealth.com.About Encompass HealthEncompass Health (NYSE: EHC) ...

Core Viewpoint - Encompass Health Corporation (EHC) reported strong first-quarter 2025 results, with adjusted earnings per share (EPS) of $1.37, exceeding estimates and showing significant year-over-year growth [1][2] Financial Performance - Net operating revenues increased by 10.6% year over year to $1.5 billion, surpassing consensus estimates by 1.3% [2] - Net patient revenue per discharge grew by 3.9% year over year, with total discharges reaching 64,985, a 6.3% increase year over year [3] - Net and comprehensive income rose by 41.6% year over year to $196.5 million, while adjusted EBITDA improved by 14.9% year over year to $313.6 million, exceeding estimates [4] Operational Highlights - Total operating expenses increased by 7.2% year over year to $1.19 billion, driven by higher salaries and benefits [3] - The company added 25 beds to existing hospitals and opened one new de novo hospital during the quarter [4] Cash Flow and Capital Management - EHC generated $288.6 million in net cash from operations, a 20.9% increase year over year, with adjusted free cash flow soaring by 32.7% to $222.4 million [6] - The company repurchased shares worth $32.1 million and had approximately $458 million remaining under its buyback authorization [7] 2025 Outlook - The company updated its 2025 net operating revenue forecast to between $5.85 billion and $5.925 billion, indicating a 9.6% rise from 2024 [8] - Adjusted EBITDA is now estimated to be between $1.185 billion and $1.22 billion, reflecting a 9% growth from 2024 [9] - Adjusted EPS from continuing operations is expected to range from $4.85 to $5.10, suggesting a 12.3% increase from 2024 [9] Growth Strategy - EHC aims to open seven de novo hospitals and add 340 beds in 2025, with plans to add 100-120 beds to existing hospitals [10] - Over the 2023-2027 period, the company targets the inauguration of six to ten de novos each year and a compound annual growth rate (CAGR) of 6-8% in discharges [11]

Encompass Health (EHC) Q1 2025 Earnings Call April 26, 2025 01:15 AM ET Company Participants Mark Miller - Chief Investor Relations OfficerMark Tarr - CEO, President & DirectorDouglas Coltharp - Executive VP & CFONone - ExecutiveWhit Mayo - Senior Managing DirectorA.J. Rice - Managing DirectorJared Haase - Equity Research AssociateAndrew Mok - DirectorJohn Ransom - Managing Director, Director of Healthcare Research Conference Call Participants Pito Chickering - AnalystMatthew Gillmor - Director & Equity Res ...

Encompass Health (EHC) came out with quarterly earnings of $1.37 per share, beating the Zacks Consensus Estimate of $1.19 per share. This compares to earnings of $1.12 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 15.13%. A quarter ago, it was expected that this rehabilitation hospital operator would post earnings of $1.02 per share when it actually produced earnings of $1.17, delivering a surprise of 14.71%. There are no e ...

Exhibit 99.1 Media Contact April 24, 2025 Polly Manuel, 205 969-4532 polly.manuel@encompasshealth.com Investor Relations Contact Mark Miller, 205 970-5860 mark.miller@encompasshealth.com Encompass Health reports results for first quarter 2025 Increases full-year guidance BIRMINGHAM, Ala. - Encompass Health Corporation (NYSE: EHC), the largest owner and operator of inpatient rehabilitation hospitals in the United States, today reported its results of operations for the first quarter ended March 31, 2025. Sum ...